Globe Life (NYSE:GL) Issues FY 2026 Earnings Guidance

Key Points

• Globe Life has updated its earnings guidance for FY 2026, projecting an EPS of 14.600-15.300, compared to the consensus estimate of 15.010.
• Shares of Globe Life traded down by 0.4%, reaching a price of $135.52, with an average target price among analysts set at $152.11.
• The company announced a quarterly dividend of $0.27 per share, equating to an annualized yield of 0.8%, payable on October 31st.

Globe Life (NYSE:GL - Get Free Report) updated its FY 2026 earnings guidance on Wednesday. The company provided EPS guidance of 14.600-15.300 for the period, compared to the consensus EPS estimate of 15.010. The company issued revenue guidance of -. Globe Life also updated its FY 2025 guidance to 14.400-14.600 EPS.

Wall Street Analysts Forecast Growth

Several equities analysts recently weighed in on the stock. Morgan Stanley set a $179.00 target price on shares of Globe Life and gave the company an "overweight" rating in a report on Tuesday, October 7th. Cfra Research upgraded shares of Globe Life to a "moderate buy" rating in a report on Friday, July 25th. JPMorgan Chase & Co. lifted their price target on shares of Globe Life from $145.00 to $160.00 and gave the stock an "overweight" rating in a research note on Tuesday, July 8th. Truist Financial started coverage on shares of Globe Life in a research note on Tuesday, July 15th. They set a "buy" rating and a $150.00 price target on the stock. Finally, Weiss Ratings reaffirmed a "buy (b-)" rating on shares of Globe Life in a research note on Wednesday, October 8th. Eight research analysts have rated the stock with a Buy rating and two have assigned a Hold rating to the stock. According to MarketBeat, Globe Life has an average rating of "Moderate Buy" and a consensus price target of $152.11.

Globe Life Stock Down 0.4%

Shares of Globe Life stock traded down $0.49 during trading on Wednesday, reaching $135.52. The company had a trading volume of 681,848 shares, compared to its average volume of 631,337. The company has a market cap of $10.98 billion, a price-to-earnings ratio of 10.83 and a beta of 0.55. The firm's fifty day moving average is $139.70 and its 200-day moving average is $129.13. The company has a debt-to-equity ratio of 0.43, a quick ratio of 0.06 and a current ratio of 0.06. Globe Life has a fifty-two week low of $100.27 and a fifty-two week high of $147.83.

Globe Life (NYSE:GL - Get Free Report) last issued its earnings results on Wednesday, October 22nd. The company reported $4.81 earnings per share (EPS) for the quarter, beating analysts' consensus estimates of $4.52 by $0.29. Globe Life had a net margin of 18.11% and a return on equity of 21.24%. Globe Life has set its FY 2026 guidance at 14.600-15.300 EPS. FY 2025 guidance at 14.400-14.600 EPS. On average, analysts anticipate that Globe Life will post 13.87 EPS for the current year.

Globe Life Dividend Announcement

The firm also recently disclosed a quarterly dividend, which will be paid on Friday, October 31st. Investors of record on Friday, October 3rd will be given a dividend of $0.27 per share. This represents a $1.08 dividend on an annualized basis and a dividend yield of 0.8%. The ex-dividend date of this dividend is Friday, October 3rd. Globe Life's dividend payout ratio is currently 8.63%.

Insider Buying and Selling at Globe Life

In other Globe Life news, CEO James Matthew Darden sold 33,270 shares of the company's stock in a transaction dated Friday, July 25th. The shares were sold at an average price of $135.59, for a total value of $4,511,079.30. Following the completion of the transaction, the chief executive officer owned 49,842 shares in the company, valued at approximately $6,758,076.78. This represents a 40.03% decrease in their position. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is available at this link. Also, CEO Frank M. Svoboda sold 12,500 shares of the company's stock in a transaction dated Thursday, July 31st. The stock was sold at an average price of $141.38, for a total transaction of $1,767,250.00. Following the completion of the transaction, the chief executive officer owned 32,747 shares of the company's stock, valued at approximately $4,629,770.86. This trade represents a 27.63% decrease in their position. The disclosure for this sale can be found here. Insiders sold 84,722 shares of company stock worth $11,733,793 in the last quarter. 1.51% of the stock is currently owned by corporate insiders.

Institutional Inflows and Outflows

Institutional investors and hedge funds have recently bought and sold shares of the company. CYBER HORNET ETFs LLC bought a new position in Globe Life in the 2nd quarter worth about $28,000. MUFG Securities EMEA plc acquired a new stake in shares of Globe Life in the 2nd quarter worth approximately $31,000. Headlands Technologies LLC lifted its stake in shares of Globe Life by 893.6% in the 2nd quarter. Headlands Technologies LLC now owns 775 shares of the company's stock worth $96,000 after acquiring an additional 697 shares during the period. Quantbot Technologies LP acquired a new stake in shares of Globe Life in the 2nd quarter worth approximately $228,000. Finally, WINTON GROUP Ltd acquired a new stake in shares of Globe Life in the 2nd quarter worth approximately $308,000. Institutional investors own 81.61% of the company's stock.

About Globe Life

Globe Life Inc, through its subsidiaries, provides various life and supplemental health insurance products, and annuities to lower middle- and middle-income families in the United States. The company operates in four segments: Life Insurance, Supplemental Health Insurance, Annuities, and Investments.

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.